Kopran Limited (KOPRAN) Share Price
NSE · Healthcare · Drug Manufacturers - General · ISIN INE082A01010
Key metrics
- Market Cap
- ₹971 Cr
- P/E Ratio
- 40.61
- EPS
- 4.95
- Book Value
- 109.82
- P/B Ratio
- 1.76
- ROE
- 4.85%
- ROCE
- 8.94%
- Debt / Equity
- 0.29
- Net Margin
- 3.81%
- Revenue Growth
- 8.28%
- Profit Growth
- -33.26%
- Dividend Yield
- 1.49%
- 52W High
- ₹219.00
- 52W Low
- ₹107.00
- Market Cap Band
- small cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Kopran Limited
Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, penicillin, quinolone, anti-protozoal, sulphonamides, respiratory, tetracycline, cardiovascular, anti-diabetic, urology, pain management and anti-inflammatory, gastrointestinal, erectile dysfunction, anthemintic, anti-allergic, central nervous system, anti-malarial, anti-thyroid, and carbapenems. In addition, the company offers drugs for anti-hypertensive, neuromodulator, anti-acne, anti-infective, antibiotic, anti-thrombotic, anti-diabetic, anti-asthamatic, antihyperlipidemic, anti-convulsants, anti-anxiety, pulmonary arterial hypertension, chronic heart failure, neuropathic pain, and erosive esophagitis. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 1,156
- Promoter Holding
- 50.21%
The full Kopran Limited analysis
Create a free account to open the complete KOPRAN deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.